Cassia Life Sciences helps our partners make better scientific, operational and strategic decisions in small molecule drug discovery and early development.
We work flexibly with biotech and pharmaceutical companies, investors and early-stage ventures. Our support can range from short, independent reviews to deeper involvement in project design, outsourced R&D management, diligence or fractional leadership roles.
Small molecule drug discovery science
Small molecule discovery strategy and execution
We support discovery programmes from early hit identification through hit-to-lead, lead optimization and preclinical development planning. Our approach combines medicinal chemistry expertise with practical project leadership and a strong understanding of developability requirements.
Service examples
- Multiparameter medicinal chemistry strategy
- Hit finding and hit validation support
- Hit-to-lead and lead optimization planning
- Structure-activity and structure-property relationship analysis
- Design of novel molecules
- Synthetic strategy review
- Data analysis and project decision support
- Preliminary IP landscape awareness as part of discovery planning *
- Preclinical development preparation
* Preliminary IP assessment is provided from a discovery strategy perspective. Cassia Life Sciences does not provide legal advice and is not a patent attorney firm.
R&D operations and outsourcing
CRO, CDMO and outsourced discovery management
Many discovery projects rely on external partners. Cassia helps clients choose the right outsourced resources, establish effective working models and maintain scientific and operational oversight.
We can support both the setup of new outsourced programmes and the review or troubleshooting of ongoing collaborations.
- CRO and CDMO selection
- Service contract negotiations
- Partner onboarding
- Outsourced chemistry and biology resource management
- Project governance and review processes
- Scientific review of external data packages
- Operational troubleshooting
- Research plan costing and evolution
- Company and project setup support
Strategic and investor support
Scientific diligence, investor materials and strategic planning
Cassia supports companies and investors in evaluating opportunities, preparing for financing discussions and aligning R&D plans with commercial and portfolio objectives.
We bring a practical understanding of what makes a discovery project scientifically credible, operationally executable and strategically investable.
- Scientific and operational diligence
- Pitch deck preparation and review
- Investor discussion preparation
- Research plan and budget review
- Commercial and business development support
- Portfolio and asset positioning input
- Fractional C-suite, VP or senior advisory roles
Trusted consultant network
Where needed, Cassia can draw on a trusted network of specialist consultants across in vitro and in vivo pharmacology, toxicology, DMPK, CMC and related disciplines. This allows clients to access focused expertise while maintaining coherent scientific and operational oversight.